Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
IVAX CORP (IVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/03/2006 8-K Quarterly results
01/23/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "U.S. Federal Trade Commission Clears Teva/IVAX Merger; Closing Scheduled for January 26, 2006"
01/10/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "Teva and IVAX Announce that FTC Review Process Continues on Track and Merger Closing is Expected Shortly"
01/03/2006 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Form of amendment to Employment Agreement (Change in Control) between IVAXCorporation and certain officers (Group A)",
"Form of amendment to Employment Agreement (Change in Control) between IVAXCorporation and certain officers (Group B)"
12/22/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "Teva and IVAX Sign Consent Order, Schedule Anticipated Closing Date for Merger"
11/29/2005 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Supplemental Indenture dated November 28, 2005, between IVAX Corporation and U.S. Bank National Association, as Trustee, with respect to the 1.5% Convertible Senior Notes due 2024",
"Form of Supplemental Indenture dated November 28, 2005, between IVAX Corporation and U.S. Bank National Association, as Trustee, with respect to the 1.5% Convertible Senior Notes due 2024",
"Form of Supplemental Indenture dated November 28, 2005, between IVAX Corporation and U.S. Bank National Association, as Trustee, with respect to the 1.5% Convertible Senior Notes due 2025",
"Form of Supplemental Indenture dated November 28, 2005, between IVAX Corporation and U.S. Bank National Association, as Trustee, with respect to the 1.875% Convertible Senior Notes due 2024",
"Credit Agreement, between IVAX, Citicorp North America, Inc., Citigroup Global Markets, Inc. and the lenders party thereto"
11/25/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "IVAX ISSUES STATEMENT REGARDING OUTSTANDING CONVERTIBLE NOTES",
"IVAX ANNOUNCES TENDER OFFER FOR 4.5% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2008"
11/08/2005 8-K Results of Operations and Financial Condition
Docs: "IVAX Reports 3rd Quarter 2005 Results; Revenues up 41% to Record $617.7 Million; Net Income up 25% to $55.4 Million; EPS up 18% to $0.20"
10/27/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release issued October 27, 2005"
10/12/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "Teva and IVAX Receive FTC Request for Additional Information"
10/03/2005 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement, Financial...
Docs: "IVAX Announces Conversion Period for 1.875% Convertible Notes",
"Notice of Convertibility"
09/21/2005 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Form of amendment to Employment Agreement (Change in Control) between IVAX Corporation and certain officers"
09/21/2005 8-K Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
08/08/2005 8-K Entry into a Material Definitive Agreement
08/01/2005 8-K Results of Operations and Financial Condition
Docs: "IVAX Reports Results For Second Quarter 2005; Revenues Up 24% To $577.3 Million; Net Income $45.6 Million; EPS $0.17"
07/29/2005 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among IVAX Corporation, TEVA Pharmaceutical Industries Limited, Ivory Acquisition Sub, Inc. and Ivory Acquisition Sub II, Inc",
"Stockholders Agreement, with Phillip Frost, M.D., Frost Gamma Investments Trust, Frost-Nevada Investments Trust, Frost Alpha Investments Trust, Jack Fishman, Ph.D., Neil Flanzraich, Rafick G. Henein, Ph.D., Jane Hsiao, Ph.D., HSU Investment Limited, Charles Hsiao Family Irrevocable Trust - A and Charles Hsiao Family Irrevocable Trust - B"
05/09/2005 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
05/03/2005 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Docs: "IVAX Elects Avram Hershko, M.D., Ph.D. and Zachariah P. Zachariah, M.D. to Board of Directors"
04/28/2005 8-K Quarterly results
Docs: "IVAX Reports First Quarter 2005 Results; Revenues"
04/15/2005 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Ivax Corporation 4400 Biscayne Boulevard Miami, Florida 33137 Dear Dr. Frost:"
03/29/2005 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Notification letter of Dr. Biekert"
03/15/2005 8-K Results of Operations and Financial Condition
Docs: "IVAX Reports Revenues And Earnings For Fourth Quarter And Year 2004 And Gives Guidance For 2005 And 2006"
03/11/2005 8-K Entry into a Material Definitive Agreement
Docs: "NONQUALIFIED STOCK OPTION AGREEMENT"
02/24/2005 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
02/17/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Stock Purchase Agreement (Pursuant to Section 601(b)(2) of Regulation S-K, the exhibits and schedules to this agreement are omitted but will be provided supplementally to the Commission upon request.)",
"IVAX EXPANDS ANIMAL HEALTH BUSINESS"
02/16/2005 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Docs: "IVAX Names Richard M. Krasno, Ph.D. to Board of Directors"
02/08/2005 8-K Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
02/03/2005 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "IVAX TO DISTRIBUTE LETTER TO SHAREHOLDERS"
12/22/2004 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
11/05/2004 8-K Other Events, Financial Statements and Exhibits
Docs: "Form 10-K for the fiscal year ended December 31, 2003, including adjustments to reflect the five-for-four stock split effected August 24, 2004",
"Form 10-Q for the quarterly period ended March 31, 2004, including adjustments to reflect the five-for-four stock split effected August 24, 2004",
"Form 10-Q for the quarterly period ended June 30, 2004, including adjustments to reflect the five-for-four stock split effected August 24, 2004"
11/01/2004 8-K Results of Operations and Financial Condition
Docs: "IVAX Reports 3rd Quarter 2004 Results; Revenues up 22% to $439.1 Million; Net Income up 105% to $44.4 Million; EPS up 89% to $.17 -Pre-Split $.22-; 2004 Guidance Reconfirmed"
10/12/2004 8-K Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
07/28/2004 8-K Results of Operations and Financial Condition
Docs: "IVAX Reports Record Results for Second Quarter of 2004; Revenues up 35% to a Record $464.0 Million; Gross Profit up 49% to a Record $224.6 Million"
06/25/2004 8-K Other events
Docs: "Amendment No. 1 to the Rights Agreement, between IVAX Corporation and Chase Mellon Shareholder Services, L.L.C., with respect to the IVAX Corporation Shareholders Rights Plan"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy